Barclays’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-37,971
| Closed | -$1.76M | – | 4481 |
|
|
2023
Q2 | $1.76M | Buy |
37,971
+16,655
| +78% | +$774K | ﹤0.01% | 1816 |
|
|
2023
Q1 | $611K | Buy |
21,316
+8,179
| +62% | +$234K | ﹤0.01% | 2504 |
|
|
2022
Q4 | $410K | Buy |
13,137
+7,181
| +121% | +$224K | ﹤0.01% | 2710 |
|
|
2022
Q3 | $120K | Buy |
5,956
+4,531
| +318% | +$91.3K | ﹤0.01% | 3344 |
|
|
2022
Q2 | $22K | Sell |
1,425
-1,436
| -50% | -$22.2K | ﹤0.01% | 4058 |
|
|
2022
Q1 | $55K | Buy |
+2,861
| New | +$55K | ﹤0.01% | 3969 |
|